Evidence map›Paper›PMID 27305639›Full record

ReviewEpigenomics2016

The importance of detailed epigenomic profiling of different cell types within organs.

Theresa Ryan Stueve, Crystal N Marconett, Beiyun Zhou, Zea Borok, Ite A Laird-Offringa

Abstract readReview
In one paragraph

Review in Epigenomics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. DNA Methylation and Type 2 Diabetes: Novel Biomarkers for Risk Assessment?International journal of molecular sciences · 2021
    Review
  10. Article
  11. AI applications in functional genomics.Computational and structural biotechnology journal · 2021
    Review
  12. Article
  13. Complexities of Understanding Function from CKD-Associated DNA Variants.Clinical journal of the American Society of Nephrology : CJASN · 2020
    Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Theresa Ryan StueveDepartment of Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, USA.
Crystal N MarconettDepartment of Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, USA.
Beiyun ZhouNorris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, USA.
Zea BorokNorris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, USA.
Ite A Laird-OffringaDepartment of Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, USA.

Funding

Training Grant in Genomic Analysis and InterpretationT32ES013678 · NIEHS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI GAUDERMAN, WILLIAM JAMES, MCCONNELL, ROB S · 2006 to 2023
$5.6M
Role of Chaperone GRP78 and Mitochondrial Dysfunction in ER Stress-Mediated Pulmonary FibrosisR01HL114959 · NHLBI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ANN, DAVID K., ZHOU, BEIYUN · 2013 to 2025
$4.2M
Epigenetic profiling of human alveolar epithelial cells in health and diseaseR01HL114094 · NHLBI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BOROK, ZEA, OFFRINGA, ITE A · 2011 to 2015
$3.3M
Mechanisms of beta-catenin signaling in alveolar epithelial cell differentiationR01HL112638 · NHLBI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BOROK, ZEA, KAHN, MICHAEL · 2013 to 2016
$2.2M
Molecular programming of AEC differentiation: role of forkhead factorsR37HL062569 · NHLBI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BOROK, ZEA · 2010 to 2014
$2.2M
Role of claudin 18 in regulation of lung stem/progenitor cell homeostasisR01HL126877 · NHLBI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BOROK, ZEA · 2016 to 2017
$587k
NHLBI NIH HHS R01 HL112638NHLBI NIH HHS R01 HL114094NHLBI NIH HHS R01 HL114959NHLBI NIH HHS R01 HL126877NHLBI NIH HHS R37 HL062569NIEHS NIH HHS T32 ES013678
6 · The paper itself

Abstract

The human body consists of hundreds of kinds of cells specified from a single genome overlaid with cell type-specific epigenetic information. Comprehensively profiling the body's distinct epigenetic landscapes will allow researchers to verify cell types used in regenerative medicine and to determine the epigenetic effects of disease, environmental exposures and genetic variation. Key marks/factors that should be investigated include regions of nucleosome-free DNA accessible to regulatory factors, histone marks defining active enhancers and promoters, DNA methylation levels, regulatory RNAs, and factors controlling the three-dimensional conformation of the genome. Here we use the lung to illustrate the importance of investigating an organ's purified cell epigenomes, and outline the challenges and promise of realizing a comprehensive catalog of primary cell epigenomes.

Indexed as

Epigenesis, GeneticAnimalsCells, CulturedDNA MethylationGenetic VariationHumansLungOrgan SpecificityPromoter Regions, GeneticSingle-Cell AnalysisTranscriptomecell-specific epigenomesChIP-seqDNA methylationenvironmental epigeneticsepigenomicshistone modificationlungorgan

Identifiers

PMID27305639
PMCPMC5066118

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.